Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gamba, S."'
Autor:
Marchetti M; Department of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy. Electronic address: marina.r.marchetti@gmail.com., Russo L; Department of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy., Giaccherini C; Department of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy., Gamba S; Department of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy., Falanga A; Department of Immunohematology and Transfusion Medicine, ASST Papa Giovanni XXIII, Bergamo, Italy; School of Medicine and Surgery, University of Milan Bicocca, Milan, Italy.
Publikováno v:
Thrombosis research [Thromb Res] 2022 May; Vol. 213 Suppl 1, pp. S46-S50. Date of Electronic Publication: 2022 May 26.
Autor:
Costanzo S; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Parisi R; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., De Curtis A; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Gamba S; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Russo L; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Persichillo M; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Panzera T; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Marchetti M; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Cerletti C; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., de Gaetano G; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Falanga A; Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.; School of Medicine, University of Milan Bicocca, Monza, Italy., Donati MB; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy., Iacoviello L; Department of Epidemiology and Prevention, IRCCS Neuromed, Pozzilli, Isernia, Italy.; Department of Medicine and Surgery, Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2021 Apr; Vol. 121 (4), pp. 449-456. Date of Electronic Publication: 2020 Oct 18.
Autor:
Crippa M; Regenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale (EOC), Via Tesserete 46, 6900 Lugano, Switzerland. matteo.moretti@eoc.ch., Bersini S, Gilardi M, Arrigoni C, Gamba S, Falanga A, Candrian C, Dubini G, Vanoni M, Moretti M
Publikováno v:
Lab on a chip [Lab Chip] 2021 Mar 21; Vol. 21 (6), pp. 1061-1072. Date of Electronic Publication: 2021 Feb 01.
Autor:
Marchetti M; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Giaccherini C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Masci G; Oncology Unit, IRCCS Humanitas Institute, Rozzano, Italy., Verzeroli C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Russo L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Celio L; Oncology Unit, IRCCS National Cancer Institute, Milan, Italy., Sarmiento R; Oncology Unit, Hospital San Filippo Neri, Rome, Italy., Gamba S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Tartari CJ; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Diani E; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Vignoli A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy., Malighetti P; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo, Italy., Spinelli D; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo, Italy., Kuderer NM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Nichetti F; Oncology Unit, IRCCS National Cancer Institute, Milan, Italy., Minelli M; Oncology Unit, Hospital San Giovanni Addolorata, Rome, Italy., Tondini C; Oncology Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy., Barni S; Oncology Unit, Hospital Papa Giovanni XXIII, Bergamo, Italy., Giuliani F; Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, Bari, Italy., Petrelli F; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio, Italy., D'Alessio A; Medical Oncology and Internal Medicine, Policlinico San Marco, Bergamo, Italy., Gasparini G; Oncology Unit, Hospital San Filippo Neri, Rome, Italy., Labianca R; Department Oncology Bergamo Province, Hospital Papa Giovanni XXIII, Bergamo, Italy., Santoro A; Oncology Unit, IRCCS Humanitas Institute, Rozzano, Italy., De Braud F; Oncology Unit, IRCCS National Cancer Institute, Milan, Italy., Falanga A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.; School of Medicine, University of Milan Bicocca, Italy.
Publikováno v:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2020 Sep; Vol. 18 (9), pp. 2220-2231. Date of Electronic Publication: 2020 Aug 11.
Autor:
Giaccherini C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Marchetti M; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Masci G; Oncology Unit, IRCCS Humanitas Institute, Rozzano., Verzeroli C; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Russo L; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Celio L; Oncology Unit, IRCCS National Cancer Institute, Milan., Sarmiento R; Oncology Unit, Hospital San Filippo Neri, Rome., Gamba S; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Tartari CJ; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Diani E; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Vignoli A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo., Malighetti P; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo., Spinelli D; Department of Management, Information and Production Engineering, University of Bergamo, Bergamo., Tondini C; Oncology Unit, Hospital Papa Giovanni XXIII, Bergamo., Barni S; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio., Giuliani F; Oncology Unit, IRCCS Cancer Institute Giovanni Paolo II, Bari., Petrelli F; Oncology Unit, Hospital Treviglio-Caravaggio, Treviglio., D'Alessio A; Medical Oncology and Internal Medicine, Policlinico San Marco, Zingonia-Bergamo., Gasparini G; Oncology Unit, Hospital San Filippo Neri, Rome., De Braud F; Oncology Unit, IRCCS National Cancer Institute, Milan., Santoro A; Oncology Unit, IRCCS Humanitas Institute, Rozzano., Labianca R; Department Oncology Bergamo Province, Hospital Papa Giovanni XXIII, Bergamo., Falanga A; Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo annafalanga@yahoo.com.; University of Milan Bicocca, School of Medicine and Surgery, Milan, Italy.
Publikováno v:
Haematologica [Haematologica] 2020 Jun; Vol. 105 (6), pp. 1704-1711. Date of Electronic Publication: 2019 Sep 26.
Autor:
Giovanna Masci, Roberto Labianca, Sara Gamba, Cinzia Giaccherini, Filippo de Braud, Fausto Petrelli, Anna Falanga, Alfonso Vignoli, Erika Diani, Paolo Malighetti, Laura Russo, Armando Santoro, Carmen J Tartari, Carlo Tondini, Marina Marchetti, Giampietro Gasparini, Daniele Spinelli, Francesco Giuliani, Luigi Celio, Cristina Verzeroli, Andrea D'Alessio, Sandro Barni, Roberta Sarmiento
Publikováno v:
Haematologica
In cancer patients, hypercoagulability is a common finding. It has been associated with an increased risk of venous thromboembolism, but also to tumor proliferation and progression. In this prospective study of a large cohort of breast cancer patient
Autor:
Marina Marchetti, Cinzia Giaccherini, Giovanna Masci, Cristina Verzeroli, Laura Russo, Luigi Celio, Roberta Sarmiento, Sara Gamba, Carmen J. Tartari, Erika Diani, Alfonso Vignoli, Paolo Malighetti, Daniele Spinelli, Nicole M. Kuderer, Federico Nichetti, Mauro Minelli, Carlo Tondini, Sandro Barni, Francesco Giuliani, Fausto Petrelli, Andrea D’Alessio, Giampietro Gasparini, Roberto Labianca, Armando Santoro, Filippo De Braud, Anna Falanga, Francesca Schieppati, Antonia Martinetti, Elisabetta Gennaro, Mara Ghilardi
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(9)
Background: Cancer patients present with a hypercoagulable state often associated with poor disease prognosis. Objectives: This study aims to evaluate whether thrombin generation (TG), a global coagulation test, may be a useful tool to improve the id